Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to -$1.8 million.

  • Champions Oncology's Net Cash Flow fell 121086.96% to -$1.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.8 million, marking a year-over-year increase of 30884.38%. This contributed to the annual value of $7.2 million for FY2025, which is 19556.0% up from last year.
  • According to the latest figures from Q4 2025, Champions Oncology's Net Cash Flow is -$1.8 million, which was down 121086.96% from $540000.0 recorded in Q3 2025.
  • In the past 5 years, Champions Oncology's Net Cash Flow registered a high of $6.6 million during Q2 2025, and its lowest value of -$5.2 million during Q3 2023.
  • In the last 5 years, Champions Oncology's Net Cash Flow had a median value of $68000.0 in 2024 and averaged -$1850.0.
  • The largest annual percentage gain for Champions Oncology's Net Cash Flow in the last 5 years was 45583.78% (2025), contrasted with its biggest fall of 121086.96% (2025).
  • Quarter analysis of 5 years shows Champions Oncology's Net Cash Flow stood at $783000.0 in 2021, then surged by 253.51% to $2.8 million in 2022, then tumbled by 76.73% to $644000.0 in 2023, then plummeted by 121.43% to -$138000.0 in 2024, then plummeted by 1210.87% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q4 2025, $540000.0 for Q3 2025, and $6.6 million during Q2 2025.